Mayne Pharma Group Ltd Cash Flow Conversion Efficiency

Latest as of June 2025: 0.086x

Mayne Pharma Group Ltd cash flow conversion efficiency. Based on the latest financial reports, Mayne Pharma Group Ltd (MYX) has a cash flow conversion efficiency ratio of 0.086x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$31.98 Million ≈ $22.63 Million USD) by net assets (AU$370.28 Million ≈ $262.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Mayne Pharma Group Ltd for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Mayne Pharma Group Ltd (2007–2025)

Cash flow conversion efficiency of Mayne Pharma Group Ltd from 2007 to 2025. This chart illustrates how Mayne Pharma Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Mayne Pharma Group Ltd (MYX) share price today for real-time trading data and today's change.

Mayne Pharma Group Ltd Cash Flow Conversion Ratio Explained

Mayne Pharma Group Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mayne Pharma Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mayne Pharma Group Ltd ranked by their cash flow conversion efficiency. Review MYX free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Sajodaerim KO:003960	0.051x
Samyoung Elec KO:005680	0.016x
Humax Co. Ltd KQ:115160	-0.018x
Mercator Medical S.A. WAR:MRC	0.052x
Cegedim S.A. PA:CGM	0.260x
Catella AB (publ) ST:CAT-B	0.009x
Korea Real Estate Investment & Trust Co Ltd KO:034830	-0.011x
Tavia Acquisition Corp. Unit NASDAQ:TAVIU	-0.001x

Annual Cash Flow Conversion Efficiency for Mayne Pharma Group Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Mayne Pharma Group Ltd from 2007 to 2025. Also see MYX asset base for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$370.28 Million ≈ $262.00 Million	AU$17.47 Million ≈ $12.36 Million	0.047x	+240.05%
2024-06-30	AU$454.19 Million ≈ $321.37 Million	AU$-15.30 Million ≈ $-10.83 Million	-0.034x	+49.97%
2023-06-30	AU$634.36 Million ≈ $448.85 Million	AU$-42.71 Million ≈ $-30.22 Million	-0.067x	-420.56%
2022-06-30	AU$557.12 Million ≈ $394.20 Million	AU$-7.21 Million ≈ $-5.10 Million	-0.013x	-121.12%
2021-06-30	AU$771.58 Million ≈ $545.94 Million	AU$47.26 Million ≈ $33.44 Million	0.061x	-36.02%
2020-06-30	AU$1.04 Billion ≈ $737.50 Million	AU$99.78 Million ≈ $70.60 Million	0.096x	-8.94%
2019-06-30	AU$1.01 Billion ≈ $717.52 Million	AU$106.61 Million ≈ $75.43 Million	0.105x	+6.87%
2018-06-30	AU$1.24 Billion ≈ $873.95 Million	AU$121.50 Million ≈ $85.97 Million	0.098x	+947.27%
2017-06-30	AU$1.31 Billion ≈ $928.62 Million	AU$-15.24 Million ≈ $-10.78 Million	-0.012x	-108.16%
2016-06-30	AU$376.22 Million ≈ $266.20 Million	AU$53.50 Million ≈ $37.86 Million	0.142x	+104.38%
2015-06-30	AU$322.20 Million ≈ $227.98 Million	AU$22.42 Million ≈ $15.86 Million	0.070x	-57.60%
2014-06-30	AU$159.27 Million ≈ $112.70 Million	AU$26.14 Million ≈ $18.49 Million	0.164x	+189.81%
2013-06-30	AU$120.89 Million ≈ $85.54 Million	AU$6.84 Million ≈ $4.84 Million	0.057x	-87.06%
2012-06-30	AU$30.60 Million ≈ $21.65 Million	AU$13.39 Million ≈ $9.47 Million	0.437x	+158.83%
2011-06-30	AU$24.17 Million ≈ $17.10 Million	AU$4.09 Million ≈ $2.89 Million	0.169x	-57.89%
2010-06-30	AU$25.55 Million ≈ $18.08 Million	AU$10.26 Million ≈ $7.26 Million	0.401x	+186.15%
2009-06-30	AU$7.70 Million ≈ $5.45 Million	AU$-3.59 Million ≈ $-2.54 Million	-0.466x	-76.14%
2008-06-30	AU$11.44 Million ≈ $8.09 Million	AU$-3.03 Million ≈ $-2.14 Million	-0.265x	-209.97%
2007-06-30	AU$14.51 Million ≈ $10.27 Million	AU$-1.24 Million ≈ $-876.47K	-0.085x	--

About Mayne Pharma Group Ltd

AU:MYX Australia Medical Distribution

Market Cap

$146.02 Million

AU$206.36 Million AUD

Market Cap Rank

#17578 Global

#514 in Australia

Share Price

AU$2.54

Change (1 day)

+1.60%

52-Week Range

AU$2.13 - AU$5.79

All Time High

AU$41.75